India Supreme Court Panel Delays Ruling On Novartis Glivec Appeal
This article was originally published in PharmAsia News
Executive Summary
India's two-judge panel of the Supreme Court delayed issuing a decision on an appeal by Novartis of the government's denial of a patent for its Glivec (imatinib) blood-cancer drug.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.